GE Healthcare Life Sciences Bioprocessing Solutions for Development and Manufacture of Biotherapeutics and Vaccines
GE Healthcare Life Sciences provides bioprocessing products and services to the biopharmaceutical industry for the development and production of vaccines and biotherapeutics.
The company uses its scientific knowledge and technical expertise to help biomanufacturers increase speed-to-market, reduce costs, and improve productivity.
Single-use, upstream and downstream bioprocessing
GE provides a wide range of integrated products and solutions to meet the needs of the biopharmaceutical industry for upstream and downstream bioprocessing.
Its portfolio includes products for cell culture and fermentation (HyClone™ cell culture media, sera, process liquids, ReadyToProcess WAVE™, Xcellerex™ bioreactors and Xcellerex fermentors), chromatography (ÄKTA™ chromatography system, chromatography columns and resins, and in-line conditioning systems), filtration (tangential flow filtration and ULTA™ normal flow filtration products), and liquid preparation and management (Xcellerex single-use mixers, ReadyKart™ mobile processing stations, ReadyToProcess™ storage bins and assemblies, and ReadyCircuit™ bag assemblies and ReadyMate™ connectors).
GE also offers single-use systems, components, assemblies, and manufacturing facility solutions.
Biomanufacturing design and management for therapies and vaccines
GE Healthcare offers drug developers an array of biomanufacturing solutions that increase efficiency and optimize productivity. GE’s Enterprise Solutions provide an end-to-end platform for biologics management with innovative, modular solutions for the launch of new molecules, bringing biosimilars to an emerging market, or expanding biomanufacturing capacity to support production needs. Enterprise Solutions provides clients with new options to achieve their biomanufacturing goals.
FlexFactory™ is an integrated, single-use, or hybrid biomanufacturing platform that provides rapid access to current good manufacturing practice (cGMP) manufacturing capacity, while providing flexibility.
The KuBio™ facilities and BioPark campus each offer a configurable design space to meet the client’s biomanufacturing needs. These turnkey facility solutions delay capital investment, reduce business risk, and improve speed-to-market.
Manufacturing support and strategies
GE provides a wide range of Fast Trak™ support services for drug development applications. Performed with open collaboration and transparency, the company offers services to support cell culture medium development, upstream and downstream process development, clinical manufacturing, analytical development, quality control, and process transfer.
In addition, GE offers education courses globally for practical, hands-on bioprocess training. Fast Trak courses are offered at 9 locations worldwide, in addition to on-demand courses.
Products and Services
Changes in the bioprocessing market demand new ways of thinking. The industry needs smart solutions for easily scaling up or down production. Financial and production risks must also be minimized while adhering to strict demands from regulating bodies.
Single-use manufacturing solutions cover technical, operational, economic and strategic considerations for single-use technology and implementation.
Fast Trak Services
Expertise lies in knowing what needs to be done and what does not need to be done. These factors are equally important for reducing time-to-market.
Case Study: Bioprocess Security of Supply
Human medicine manufacturers need suppliers who will consistently deliver high-quality consumables over decades and communicate transparently when changes are required.
Roivant Sciences Accelerates Process Development to Speed Orphan Therapy to Market
Although the demographic of orphan therapies is small, making therapies for rare diseases available has a huge impact for the affected patients.
Fast Track Services: Ongoing Collaboration to Accelerate Biosimilar Approval in China
This case study outlines Pfizer's decision to use GE's Fast Track services to help achieve approval for two biosimilar monoclonal antibodies (mAb) in China.
Fast Trak Services: A collaborative Project to Accelerate Downstream Biosimilar Process Development
Biosimilars represent an innovative solution to benefit both patients and healthcare systems by reducing the burden of rising treatment costs.
Cell Culture Scale-Up
Achieving the delicate balance of product quantity, quality, cost, and speed is difficult in dynamic circumstances. Add in challenges such as validation of new cell culture media or changes in scale, and this balance can seem just out of reach.
Clover Biopharmaceuticals has chosen GE Healthcare’s biomanufacturing platform FlexFactory for its new facility located in Changxing, Zhejiang, China.Read more
United BioPharma (UBP) has selected GE Healthcare’s FlexFactory manufacturing platform for its new facility focusing on late-stage clinical and commercial production capacity of therapeutic monoclonal antibodies in Hsinchu Industrial Park, Taiwan.Read more
GE Healthcare has announced that Dr. Reddy’s Laboratories will be installing India’s first-ever FlexFactory, a single-use manufacturing platform to expand the biologics production capacity at its facility in Hyderabad, India.Read more
Munzinger Strasse 5
100 Results Way
United States of America